# Pulse Biosciences, Inc.: Form 8-K, filed Feb 19, 2026

- Company: [Pulse Biosciences, Inc.](/companies/plse.md) (CIK 1625101)
- Form: 8-K
- Filed: 2026-02-19
- Accepted by EDGAR: Feb 19, 2026, 16:09 ET
- Period: 2026-02-18
- Accession: 0001437749-26-004726
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/plse20260218_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/plse20260218_8k.htm

Filed Feb 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-004726. Last ingested by Listed: Nov 6, 2026, 12:23 ET. No prices; not investment advice.